Wednesday, February 01, 2017 by: Howard Roark
(Natural News) It would be naive to think that the FDA endeavors to protect the public’s health as its primary focus. Indeed, that would be a conflict of interest, as it serves its master, the pharmaceutical industry. Has the Food and Drug Administration engineered a shortage of intravenous vitamin C as part of an overall attack on natural and non-toxic approaches to healing that compete with prescription drugs? An analysis by Natural Blaze would suggest that the answer is yes.
Natural Blaze claims that a critical shortage of IV bags in general followed an FDA ban on the mass production of intravenous vitamin C. The FDA limited the availability of IV-C and the pharmaceutical industry halted production of injectable vitamins and minerals, after a 60 minute story about the miraculous recovery of a swine flu patient on life support. Because of the shortage of IV-C, doctors called upon compounding pharmacies to produce it. But the FDA began to limit compounding pharmacies after injectable steroids produced by the New England Compounding Center were contaminated with a fungus that caused a deadly outbreak of meningitis. Here is an example of an entire industry being punished for the dubious practices of one compounding pharmacy.